Literature DB >> 31899933

Cystic fibrosis in the year 2020: A disease with a new face.

Kris De Boeck1.   

Abstract

The autosomal recessive disease cystic fibrosis (CF) was once untreatable and deadly in childhood, but now most patients survive to adulthood. Many countries have instituted CF newborn screening because early diagnosis improves outcome. CF research has greatly intensified following the discovery of the CF transmembrane conductance regulator (CFTR) gene, which has more than 2000 different mutations. For patients with common mutations like F508del, CFTR modulators are life transforming and may even prevent major complications if started early in childhood. For some patients with rare CFTR mutations, a treatment path still needs to be developed.
Conclusion: This review provides a general update on CF, including screening and current and future treatment.
© 2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cystic fibrosis; diagnosis; early screening; genetic mutations; survival rates

Mesh:

Year:  2020        PMID: 31899933     DOI: 10.1111/apa.15155

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  38 in total

Review 1.  Increasing life expectancy in cystic fibrosis: Advances and challenges.

Authors:  Kimberly A McBennett; Pamela B Davis; Michael W Konstan
Journal:  Pediatr Pulmonol       Date:  2021-11-11

2.  The association between Sodium Urinary Discharge (FENa) and growth parameters in pediatrics with cystic fibrosis.

Authors:  Mohsen Reisi; Majid Keivanfar; Mahboobe Rezaie; Silva Hovsepian
Journal:  Am J Clin Exp Urol       Date:  2022-08-15

3.  Surface Hydration Protects Cystic Fibrosis Airways from Infection by Restoring Junctional Networks.

Authors:  Juliette L Simonin; Alexandre Luscher; Davide Losa; Mehdi Badaoui; Christian van Delden; Thilo Köhler; Marc Chanson
Journal:  Cells       Date:  2022-05-09       Impact factor: 7.666

4.  Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.

Authors:  Paul Breen; Madsen Zimbric; Kristopher Opron; Lindsay J Caverly
Journal:  mSphere       Date:  2022-04-28       Impact factor: 5.029

Review 5.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

Review 6.  The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy.

Authors:  Philip M Farrell; Michael J Rock; Mei W Baker
Journal:  Genes (Basel)       Date:  2020-04-08       Impact factor: 4.096

7.  Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia.

Authors:  Hanaa Hasan Banjar; Lin Tuleimat; Abdul Aziz Agha El Seoudi; Ibrahim Mogarri; Sami Alhaider; Imran Yaqoob Nizami; Talal AlMaghamsi; Sara Andulrahman Alkaf; Nabil Moghrabi
Journal:  Ann Saudi Med       Date:  2020-02-06       Impact factor: 1.526

8.  Effect of malnutrition in infants with cystic fibrosis in India: An underestimated danger.

Authors:  Leenath Thomas; Shincy T John; B Arul P Lionel; Grace Rebekah; Madhan Kumar; Anu Punnen; Sneha Varkki
Journal:  J Family Med Prim Care       Date:  2021-05-31

9.  An investigation on parenting stress of children with cystic fibrosis.

Authors:  Grazia Isabella Continisio; Nicola Serra; Assunta Guillari; Maria Teresa Civitella; Angela Sepe; Silvio Simeone; Gianpaolo Gargiulo; Silvia Toscano; Maria Rosaria Esposito; Valeria Raia; Teresa Rea
Journal:  Ital J Pediatr       Date:  2020-03-18       Impact factor: 2.638

Review 10.  The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery.

Authors:  Virginie Scotet; Carine L'Hostis; Claude Férec
Journal:  Genes (Basel)       Date:  2020-05-26       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.